Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Michael Meister

Showing results (51-60 of 117) with videos related to

Pageof 12
Sort By:
Lung Cancer (Amsterdam, Netherlands)|January 9, 2013
Mesenchymal stem cells in non-small cell lung cancer--different from others? Insights from comparative molecular and functional analysesSandra Gottschling, Martin Granzow, Ruprecht Kuner, et al.
Anticancer Research|October 23, 2009
Expression and mutational status of PDGFR in thymic tumoursMichael Meister, Philip Kahl, Thomas Muley, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|May 17, 2012
Early detection of lung cancer by molecular markers in endobronchial epithelial-lining fluidNicolas Kahn, Michael Meister, Ralf Eberhardt, et al.
Plos One|October 24, 2018
Molecular signatures in IASLC/ATS/ERS classified growth patterns of lung adenocarcinomaHeike Zabeck, Hendrik Dienemann, Hans Hoffmann, et al.
Lung Cancer (Amsterdam, Netherlands)|May 12, 2018
The combination of the blood based tumor biomarkers cytokeratin 19 fragments (CYFRA 21-1) and carcinoembryonic antigen (CEA) as a potential predictor of benefit from adjuvant chemotherapy in early stage squamous cell carcinoma of the lung (SCC)Thomas Muley, Vinzent Rolny, Ying He, et al.
Cancer Letters|August 22, 2006
Mutational status of the epidermal growth factor receptor (EGFR) gene in thymomas and thymic carcinomasMichael Meister, Peter Schirmacher, Hendrik Dienemann, et al.
Clinical Proteomics|August 4, 2015
Blood-sampling collection prior to surgery may have a significant influence upon biomarker concentrations measuredNicolas Kahn, Julia Riedlinger, Markus Roeßler, et al.
Journal of Virology|March 28, 2020
Impact of Natural or Synthetic Singletons in the Capsid of Human Bocavirus 1 on Particle Infectivity and ImmunoreactivityJulia Fakhiri, Kai-Philipp Linse, Mario Mietzsch, et al.
International Journal of Oncology|January 20, 2017
AURKA, DLGAP5, TPX2, KIF11 and CKAP5: Five specific mitosis-associated genes correlate with poor prognosis for non-small cell lung cancer patientsMarc A Schneider, Petros Christopoulos, Thomas Muley, et al.
Tumour Biology : the Journal of the International Society for Oncodevelopmental Biology and Medicine|October 16, 2023
CYFRA 21-1, CA 125 and CEA provide additional prognostic value in NSCLC patients with stable disease at first CT scanThomas Muley, Mark A Schneider, Michael Meister, et al.
Pageof 12

Showing results (51-60 of 117) with videos related to

Sort By:
Pageof 12
Lung Cancer (Amsterdam, Netherlands)|January 9, 2013
Mesenchymal stem cells in non-small cell lung cancer--different from others? Insights from comparative molecular and functional analysesSandra Gottschling, Martin Granzow, Ruprecht Kuner, et al.
Anticancer Research|October 23, 2009
Expression and mutational status of PDGFR in thymic tumoursMichael Meister, Philip Kahl, Thomas Muley, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|May 17, 2012
Early detection of lung cancer by molecular markers in endobronchial epithelial-lining fluidNicolas Kahn, Michael Meister, Ralf Eberhardt, et al.
Plos One|October 24, 2018
Molecular signatures in IASLC/ATS/ERS classified growth patterns of lung adenocarcinomaHeike Zabeck, Hendrik Dienemann, Hans Hoffmann, et al.
Lung Cancer (Amsterdam, Netherlands)|May 12, 2018
The combination of the blood based tumor biomarkers cytokeratin 19 fragments (CYFRA 21-1) and carcinoembryonic antigen (CEA) as a potential predictor of benefit from adjuvant chemotherapy in early stage squamous cell carcinoma of the lung (SCC)Thomas Muley, Vinzent Rolny, Ying He, et al.
Cancer Letters|August 22, 2006
Mutational status of the epidermal growth factor receptor (EGFR) gene in thymomas and thymic carcinomasMichael Meister, Peter Schirmacher, Hendrik Dienemann, et al.
Clinical Proteomics|August 4, 2015
Blood-sampling collection prior to surgery may have a significant influence upon biomarker concentrations measuredNicolas Kahn, Julia Riedlinger, Markus Roeßler, et al.
Journal of Virology|March 28, 2020
Impact of Natural or Synthetic Singletons in the Capsid of Human Bocavirus 1 on Particle Infectivity and ImmunoreactivityJulia Fakhiri, Kai-Philipp Linse, Mario Mietzsch, et al.
International Journal of Oncology|January 20, 2017
AURKA, DLGAP5, TPX2, KIF11 and CKAP5: Five specific mitosis-associated genes correlate with poor prognosis for non-small cell lung cancer patientsMarc A Schneider, Petros Christopoulos, Thomas Muley, et al.
Tumour Biology : the Journal of the International Society for Oncodevelopmental Biology and Medicine|October 16, 2023
CYFRA 21-1, CA 125 and CEA provide additional prognostic value in NSCLC patients with stable disease at first CT scanThomas Muley, Mark A Schneider, Michael Meister, et al.
Pageof 12